Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

閉経後の骨粗鬆症について

W H Utian

    Lancet (London, England)
    |November 17, 1979
    PubMed
    まとめ

    No abstract available in PubMed .

    関連する実験動画

    関連する概念動画

    こちらも読む

    関連記事

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    並び替え
    Same author

    Impact of estetrol (E4) on hemostasis, metabolism and bone turnover in postmenopausal women.

    Climacteric : the journal of the International Menopause Society·2022
    Same author

    Menopausal hormone therapy for primary prevention: why the USPSTF is wrong.

    Climacteric : the journal of the International Menopause Society·2017
    Same author

    Attitudes and approaches to vaginal atrophy in postmenopausal women: a focus group qualitative study.

    Climacteric : the journal of the International Menopause Society·2013
    Same author

    A decade post WHI, menopausal hormone therapy comes full circle--need for independent commission.

    Climacteric : the journal of the International Menopause Society·2012
    Same author

    Effects of arzoxifene on bone mineral density and endometrium in postmenopausal women with normal or low bone mass.

    The Journal of clinical endocrinology and metabolism·2009
    Same author

    The International Menopause Society menopause-related terminology definitions.

    Climacteric : the journal of the International Menopause Society·2002
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    関連記事をすべて見る